BELIMUMAB
UNII 73B0K5S26A

Substance Identification & Data

This profile provides standardized clinical and technical data for Belimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 73B0K5S26A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 356547-88-1 and the RxNorm Concept ID (RxCUI) 1092437. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

73B0K5S26A

CAS Registry Number

356547-88-1

RxNorm Concept ID

1092437

Detailed Substance Profile

Preferred Name

BELIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

73B0K5S26A

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C91385

National Cancer Institute reference terminology for clinical and research data.

INN ID

8381

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OO-56

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Belimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BELIMUMAB

Common Names & Synonyms

BELIMUMAB (GENETICAL RECOMBINATION)

BELIMUMAB (GENETICAL RECOMBINATION) [JAN]

BELIMUMAB [EMA EPAR]

BELIMUMAB [INN]

BELIMUMAB [JAN]

BELIMUMAB [MART.]

BELIMUMAB [MI]

BELIMUMAB [PURPLE BOOK CDER]

BELIMUMAB [USAN]

BELIMUMAB [VANDF]

BELIMUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI (HUMAN CYTOKINE BAFF) (HUMAN MONOCLONAL LYMPHOSTAT-B HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LYMPHOSTAT-B .LAMBDA. CHAIN, DIMER